Veralto (VLTO) Competitors

In the previous week, Teradyne had 44 more articles in the media than Veralto. MarketBeat recorded 47 mentions for Teradyne and 3 mentions for Veralto. Teradyne's average media sentiment score of 1.05 beat Veralto's score of 0.41 indicating that Teradyne is being referred to more favorably in the news media.

Veralto has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, Teradyne has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market.

Teradyne has a net margin of 22.55% compared to Veralto's net margin of 17.33%. Veralto's return on equity of 34.63% beat Teradyne's return on equity.

Veralto pays an annual dividend of $0.52 per share and has a dividend yield of 0.6%. Teradyne pays an annual dividend of $0.52 per share and has a dividend yield of 0.1%. Veralto pays out 13.4% of its earnings in the form of a dividend. Teradyne pays out 9.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Veralto has increased its dividend for 1 consecutive years and Teradyne has increased its dividend for 1 consecutive years.

Veralto presently has a consensus price target of $105.88, indicating a potential upside of 25.87%. Teradyne has a consensus price target of $339.80, indicating a potential downside of 16.99%. Given Veralto's higher possible upside, research analysts clearly believe Veralto is more favorable than Teradyne.

91.3% of Veralto shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 0.4% of Veralto shares are held by company insiders. Comparatively, 0.2% of Teradyne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Veralto has higher revenue and earnings than Teradyne. Veralto is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks.

Veralto has higher revenue and earnings than Fortive. Veralto is trading at a lower price-to-earnings ratio than Fortive, indicating that it is currently the more affordable of the two stocks.

94.9% of Fortive shares are held by institutional investors. Comparatively, 91.3% of Veralto shares are held by institutional investors. 0.7% of Fortive shares are held by insiders. Comparatively, 0.4% of Veralto shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Fortive had 5 more articles in the media than Veralto. MarketBeat recorded 8 mentions for Fortive and 3 mentions for Veralto. Fortive's average media sentiment score of 1.20 beat Veralto's score of 0.41 indicating that Fortive is being referred to more favorably in the media.

Fortive has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Veralto has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

Veralto has a net margin of 17.33% compared to Fortive's net margin of 12.84%. Veralto's return on equity of 34.63% beat Fortive's return on equity.

Fortive currently has a consensus price target of $61.62, suggesting a potential upside of 0.29%. Veralto has a consensus price target of $105.88, suggesting a potential upside of 25.87%. Given Veralto's stronger consensus rating and higher probable upside, analysts clearly believe Veralto is more favorable than Fortive.

Fortive pays an annual dividend of $0.24 per share and has a dividend yield of 0.4%. Veralto pays an annual dividend of $0.52 per share and has a dividend yield of 0.6%. Fortive pays out 14.4% of its earnings in the form of a dividend. Veralto pays out 13.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Fortive has increased its dividend for 2 consecutive years and Veralto has increased its dividend for 1 consecutive years. Veralto is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Nova had 9 more articles in the media than Veralto. MarketBeat recorded 12 mentions for Nova and 3 mentions for Veralto. Nova's average media sentiment score of 1.34 beat Veralto's score of 0.41 indicating that Nova is being referred to more favorably in the media.

Nova has a net margin of 29.21% compared to Veralto's net margin of 17.33%. Veralto's return on equity of 34.63% beat Nova's return on equity.

Nova has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market. Comparatively, Veralto has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

Nova presently has a consensus price target of $518.22, indicating a potential downside of 5.90%. Veralto has a consensus price target of $105.88, indicating a potential upside of 25.87%. Given Veralto's higher possible upside, analysts plainly believe Veralto is more favorable than Nova.

83.0% of Nova shares are owned by institutional investors. Comparatively, 91.3% of Veralto shares are owned by institutional investors. 1.0% of Nova shares are owned by company insiders. Comparatively, 0.4% of Veralto shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Veralto has higher revenue and earnings than Nova. Veralto is trading at a lower price-to-earnings ratio than Nova, indicating that it is currently the more affordable of the two stocks.

Revvity currently has a consensus price target of $107.73, indicating a potential upside of 6.42%. Veralto has a consensus price target of $105.88, indicating a potential upside of 25.87%. Given Veralto's stronger consensus rating and higher possible upside, analysts plainly believe Veralto is more favorable than Revvity.

Veralto has higher revenue and earnings than Revvity. Veralto is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

In the previous week, Veralto had 1 more articles in the media than Revvity. MarketBeat recorded 3 mentions for Veralto and 2 mentions for Revvity. Revvity's average media sentiment score of 0.84 beat Veralto's score of 0.41 indicating that Revvity is being referred to more favorably in the media.

86.7% of Revvity shares are held by institutional investors. Comparatively, 91.3% of Veralto shares are held by institutional investors. 0.9% of Revvity shares are held by company insiders. Comparatively, 0.4% of Veralto shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Revvity has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Veralto has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Veralto has a net margin of 17.33% compared to Revvity's net margin of 8.26%. Veralto's return on equity of 34.63% beat Revvity's return on equity.

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Veralto pays an annual dividend of $0.52 per share and has a dividend yield of 0.6%. Revvity pays out 13.4% of its earnings in the form of a dividend. Veralto pays out 13.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Veralto has raised its dividend for 1 consecutive years. Veralto is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.